1. |
He J, Zeng H, Zhu L, et al. Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy[J]. J Genet, 2017, 96(2): 327-332. DOI: 10.1007/s12041-017-0779-6.
|
2. |
De Sanctis V, Incorvaia C, Soliman A, et al. Does insulin like growth factor-1 (IGF-1) deficiency have a "protective" role in the development of diabetic retinopathy in thalassamia major patients? [J/OL]. Mediterr J Hematol Infect Dis, 2015, 7(1): e2015038[2015-05-20]. https://www.mjhid.org/index.php/mjhid/article/view/2015.038. DOI: 10.4084/mjhid.2015.038.
|
3. |
Liang Y, Bajoria R, Jiang Y, et al. Prevalence of diabetes mellitus in Chinese children with thalassaemia major[J]. Trop Med Int Health, 2017, 22(6): 716-724. DOI: 10.1111/tmi.12876.
|
4. |
Bhoiwala DL, Dunaief JL. Retinal abnormalities in beta-thalassemia major[J]. Surv Ophthalmol, 2016, 61(1): 33-50. DOI: 10.1016/j.survophthal.2015.08.005.
|
5. |
Stultz RD, Conti FF, Kumar JB, et al. Beta-thalassemia minor manifesting as proliferative retinopathy[J/OL]. Ophthalmic Surg Lasers Imaging Retina, 2018, 49(10): e161-e164[2018-10-01]. https://pubmed.ncbi.nlm.nih.gov/30395680/. DOI: 10.3928/23258160-20181002-22.
|
6. |
Starr MR, Patel LG, Ho AC. Presumed sickle cell retinopathy in an elderly woman[J]. JAMA Ophthalmol, 2020, 138(11): 1205-1206. DOI: 10.1001/jamaophthalmol.2020.1614.
|
7. |
Duker JS, Brown GC, Ballas SK. Peripheral retinal neovascularization associated with hemoglobin C beta zero thalassemia[J]. Am J Ophthalmol, 1989, 108(3): 328-329. DOI: 10.1016/0002-9394(89)90128-1.
|
8. |
Abdalla Elsayed MEA, Mura M, Al Dhibi H, et al. Sickle cell retinopathy: a focused review[J]. Graefe’s Arch Clin Exp Ophthalmol, 2019, 257(7): 1353-1364. DOI: 10.1007/s00417-019-04294-2.
|
9. |
Sayag D, Binaghi M, Souied EH, et al. Retinal photocoagulation for proliferative sickle cell retinopathy: a prospective clinical trial with new sea fan classification[J]. Eur J Ophthalmol, 2008, 18(2): 248-254. DOI: 10.1177/112067210801800213.
|